{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:48:40Z","timestamp":1775483320395,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"DOI":"10.7759\/cureus.106520","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:55:07Z","timestamp":1775480107000},"source":"Crossref","is-referenced-by-count":0,"title":["Sustained Remission in a Patient With Depression, Chronic Insomnia, and Ischemic Heart Disease Using a Combination of Agomelatine and Mirtazapine: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohamed H","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed  A","family":"Alhaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiyah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui L","year":"2024","unstructured":"Cui L, Li S, Wang S, et al.. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024, 9:30. 10.1038\/s41392-024-01738-y","journal-title":"Signal Transduct Target Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0620","article-title":"Insomnia management: a review and update","volume":"72","author":"Shaha DP","year":"2023","unstructured":"Shaha DP. Insomnia management: a review and update. J Fam Pract. 2023, 72:S31-6. 10.12788\/jfp.0620","journal-title":"J Fam Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.10.1099","article-title":"Clinical correlates of insomnia in patients with chronic illness","volume":"158","author":"Katz DA","year":"1998","unstructured":"Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998, 158:1099-107. 10.1001\/archinte.158.10.1099","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2012.03.003","article-title":"The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism","volume":"17","author":"Finan PH","year":"2013","unstructured":"Finan PH, Smith MT. The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism. Sleep Med Rev. 2013, 17:173-83. 10.1016\/j.smrv.2012.03.003","journal-title":"Sleep Med Rev"},{"key":"ref5","article-title":"Cardiovascular considerations in antidepressant therapy: an evidence-based review","volume":"8","author":"Yekehtaz H","year":"2013","unstructured":"Yekehtaz H, Farokhnia M, Akhondzadeh S. Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent. 2013, 8:169-76.","journal-title":"J Tehran Heart Cent"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.03.013","article-title":"Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?","volume":"35","author":"Srinivasan V","year":"2011","unstructured":"Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35:913-23. 10.1016\/j.pnpbp.2011.03.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref7","article-title":"Agomelatine: a novel antidepressant","volume":"8","author":"Sansone RA","year":"2011","unstructured":"Sansone RA, Sansone LA. Agomelatine: a novel antidepressant. Innov Clin Neurosci. 2011, 8:10-4.","journal-title":"Innov Clin Neurosci"},{"key":"ref8","article-title":"Mirtazapine","author":"Jilani TN","year":"2026","unstructured":"Jilani TN, Gibbons JR, Faizy R, Saadabadi A. Mirtazapine. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2026."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000136","article-title":"Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT\/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT\/QTc study conducted in healthy volunteers","volume":"64","author":"Donazzolo Y","year":"2014","unstructured":"Donazzolo Y, Latreille M, Caillaud MA, Mocaer E, Seguin L. Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT\/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT\/QTc study conducted in healthy volunteers. J Cardiovasc Pharmacol. 2014, 64:440-51. 10.1097\/FJC.0000000000000136","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S129793","article-title":"Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE","volume":"13","author":"Medvedev VE","year":"2017","unstructured":"Medvedev VE. Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE. Neuropsychiatr Dis Treat. 2017, 13:1141-51. 10.2147\/NDT.S129793","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2014.908709","article-title":"Cardiovascular adverse effects of newer antidepressants","volume":"14","author":"Mago R","year":"2014","unstructured":"Mago R, Tripathi N, Andrade C. Cardiovascular adverse effects of newer antidepressants. Expert Rev Neurother. 2014, 14:539-51. 10.1586\/14737175.2014.908709","journal-title":"Expert Rev Neurother"},{"key":"ref12","unstructured":"American Board of Internal Medicine. ABIM Laboratory Test Reference Ranges \u0336 January 2026. (2025). Accessed. September 12, 2025: https:\/\/www.abim.org\/media\/e2wdwdqu\/laboratory-reference-ranges.pdf?utm_."},{"key":"ref13","unstructured":"National Kidney Foundation. Estimated Glomerular Filtration Rate (eGFR). (2022). Accessed. September 12, 2025: https:\/\/www.kidney.org\/kidney-topics\/estimated-glomerular-filtration-rate-egfr?utm_."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.06.016","article-title":"Synergistic mechanisms involved in the antidepressant effects of agomelatine","volume":"22","author":"Tardito D","year":"2012","unstructured":"Tardito D, Molteni R, Popoli M, Racagni G. Synergistic mechanisms involved in the antidepressant effects of agomelatine. Eur Neuropsychopharmacol. 2012, 22:S482-6. 10.1016\/j.euroneuro.2012.06.016","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605050-00007","article-title":"Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression","volume":"5","author":"Davis R","year":"1996","unstructured":"Davis R, Wilde MI. Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs. 1996, 5:389-402. 10.2165\/00023210-199605050-00007","journal-title":"CNS Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2013.06.002","article-title":"Optimizing the pharmacologic treatment of insomnia: current status and future horizons","volume":"8","author":"Minkel J","year":"2013","unstructured":"Minkel J, Krystal AD. Optimizing the pharmacologic treatment of insomnia: current status and future horizons. Sleep Med Clin. 2013, 8:333-50. 10.1016\/j.jsmc.2013.06.002","journal-title":"Sleep Med Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf050","article-title":"Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study","volume":"54","author":"Nguyen PV","year":"2025","unstructured":"Nguyen PV, Dang-Vu TT, Forest G, et al.. Mirtazapine for chronic insomnia in older adults: a randomised double-blind placebo-controlled trial-the MIRAGE study. Age Ageing. 2025, 54:afaf050. 10.1093\/ageing\/afaf050","journal-title":"Age Ageing"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199512004-00006","article-title":"Safety of mirtazapine: a review","volume":"10 Suppl 4","author":"Montgomery SA","year":"1995","unstructured":"Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol. 1995, 10 Suppl 4:37-45. 10.1097\/00004850-199512004-00006","journal-title":"Int Clin Psychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett J","year":"1998","unstructured":"Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord. 1998, 51:267-85. 10.1016\/s0165-0327(98)00224-9","journal-title":"J Affect Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402588-sustained-remission-in-a-patient-with-depression-chronic-insomnia-and-ischemic-heart-disease-using-a-combination-of-agomelatine-and-mirtazapine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:55:10Z","timestamp":1775480110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402588-sustained-remission-in-a-patient-with-depression-chronic-insomnia-and-ischemic-heart-disease-using-a-combination-of-agomelatine-and-mirtazapine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.106520","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,6]]}}}